Atracurium Besylate Injection, Solution
Product Images NDC 55150-216

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atracurium Besylate (NDC 55150-216). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Auromedics Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (50 mg per 5 mL (10 mg / mL) [single-use vial])

Package Label-principal Display Panel (50 mg per 5 mL (10 mg / mL) [single-use vial])
This is a warning about a paralyzing agent drug called Besylate Injection. The drug must be refrigerated between 2° to 8°C (36° to 46°F) and should not be frozen. Upon removal from refrigeration, the drug should be used within 14 days even if re-refrigerated. The drug comes in a 5 mL sterile single-dose vial and is made in India by AUROMEDICS. Facilities must be available for artificial respiration as the drug causes respiratory arrest. The drug is sterile and non-pyrogenic.*
FDA Label Image

Package Label-principal Display Panel (50 mg per 5 mL (10 mg / mL) [single-use vials])

Package Label-principal Display Panel (50 mg per 5 mL (10 mg / mL) [single-use vials])
This is a description of a drug called Atracurium Besylate Injection. It comes in single-dose vials with 10mg/mL dosage. The drug is used for intravenous injection and is a paralyzing agent with a warning of respiratory distress. The drug comes with precautionary measures, and each vial contains 0.9 sk byt USP along with other chemicals. The drug needs to be refrigerated at a specific temperature to maintain efficacy.*
FDA Label Image

Package Label-principal Display Panel (10 mg/mL)

Package Label-principal Display Panel (10 mg/mL)
This text appears to be a label or instruction for a medication called Atracurium Besylate Injection, USP. The concentration of the medication is 10mg/mL and it is advised to peel off and apply to a syringe. The label also has fields for date and time, as well as a space for the name or initials of the person administering the medication.*
FDA Label Image

Atracurium Besylate Chemical Structure (Atracurium Str)

Atracurium Besylate Chemical Structure (Atracurium Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.